The results of these cases supported that long-term and high-dose administration of HBOC-201 is a feasible and safe treatment modality for early and proactive correction of life-threatening severe anemia until adequate intrinsic Hb is restored, in cases where blood transfusion is not an option. The gene discussed is GSTM1; the disease is anemia (phenotype).